FDA eases compounding rules for preemie nutrition packs as supply shortage looms

The FDA is temporarily relaxing compounding rules for neonatal IV nutrition packs to address a looming supply gap. This regulatory adjustment follows the closure of two facilities, which threatened the availability of essential nutrition for preemies. By easing these requirements, the agency aims to ensure that critical neonatal IV nutrition remains accessible to patients despite the current manufacturing disruptions. The measure serves as a temporary response to maintain stability in the medical supply chain for infants.